FDA Inspection 1289106 — Shanghai Henlius Biotech, Inc.
The FDA completed an inspection of Shanghai Henlius Biotech, Inc. on July 24, 2025 in Shanghai. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 24, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Shanghai (China)
Additional Details
Sponsor, Contract Research Organization